The Future of Regulatory Automation: Breaking Down the AI and Regulatory Operations Landscape

The future of regulatory automation is the way forward for the industry. While pharmaceutical regulatory functions are already streamlining their automated processes, challenges remain in executing master data management plans and cultivating the necessary talent. Despite these hurdles, the market is ripe for automation, and new artificial intelligence (AI) and software tools are almost ready for prime time. With a machine-first mindset and a commitment to real-time evaluation of data, the path to a dynamic regulatory system is in place, bringing better outcomes to patients, payers and stakeholders faster.

AI and Regulatory Operations: Where Are We Now?

Regulatory automation is made possible by various technology tools, including AI-powered compliance management systems, which utilize algorithms and machine learning to identify and flag potential compliance risks. Other technologies used in regulatory automation include document storage solutions, submission publishing platforms and workflow management tools.

In addition to enhancing efficiency and simplifying operations, regulatory automation is essential for increasing the volume of work that pharmaceutical companies can handle while maintaining compliance and quality standards. For instance, authoring stability tables is a time-consuming and repetitive task requiring high accuracy. Utilizing a regulatory automation software tool can eliminate the need for manual data entry, enabling teams to focus on more critical tasks while enhancing accuracy and reducing the risk of errors.

Benefits of Regulatory Automation in the Life Sciences Industry

Regulatory automation helps to streamline their operations and reduce the risk of human error, ensuring that they remain compliant with the ever-evolving regulatory framework. The benefits of regulatory automation include:

• Employee engagement: Regulatory automation helps by eliminating tedious tasks and offering opportunities to work with cutting-edge technology.
• Increased efficiency: Automated processes and tools can help streamline operations, reducing the time and resources required to manage regulatory compliance.
• Reduced compliance costs: Automated systems can help reduce the costs associated with regulatory compliance, such as the costs of manual data collection and analysis, by automating these processes.
• Improved accuracy: Automated systems can help reduce the risk of human error, improving the accuracy of regulatory compliance data and reporting.
• Enhanced risk management: Automated systems can help identify and address potential compliance issues before they become problems, reducing the risk of non-compliance and reputational damage.
• Better data management: Automated systems can help ensure that regulatory data is accurate, up-to-date, and easily accessible, improving the quality of regulatory reporting.
• Increased productivity: Automated systems can help clinical research partners and organizations (CROs) focus on more value-adding and strategic activities, increasing productivity and improving overall competitiveness.

If clinical research partners are selected to support regulatory activities and operations, it is critical that the strategy of the chosen partner is focused on providing optimum quality while increasingly demonstrating efficiency and productivity and providing cost efficiency back to clients. This alignment can help ensure regulatory automation tools are effectively utilized to achieve business objectives and meet compliance requirements.

To learn more about what's on the horizon for automation and regulatory operations, read the full blog here.

The Syneos Health Insights Hub generates future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment. Driven by dynamic research, our perspectives are informed by our insights-driven product development model and crafted by subject matter experts focused on real answers to customer challenges to help guide decision making and investment. To learn more, visit insightshub.health.